The Download: making drugs in orbit and NASA’s nuclear-powered spacecraft
The article presents advancements in space-based drug manufacturing and nuclear spacecraft, highlighting both opportunities and risks. It emphasizes the ethical concerns surrounding these technologies.
The article discusses innovative developments in space technology, focusing on Varda Space Industries' plan to manufacture pharmaceuticals in microgravity. This partnership with United Therapeutics aims to explore the potential of creating drugs with enhanced properties through orbital production. Additionally, NASA is making strides in space exploration, with plans for a nuclear reactor-powered spacecraft intended for interplanetary travel by 2028. This ambitious project seeks to establish the U.S. as a leader in space technology amid increasing competition from countries like China. While these advancements could revolutionize drug production and interplanetary travel, they also raise concerns about the ethical and safety implications of such powerful technologies.
Why This Matters
This article highlights the potential risks associated with pioneering technologies such as space-based drug manufacturing and nuclear-powered spacecraft. As these innovations develop, they could lead to unforeseen safety and ethical challenges that impact society. Understanding these risks is crucial as we navigate the implications of advanced technologies in our lives.